BioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment Conference - BCDA News | RalliesBioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment Conference
B
BCDA• BioCardia to present at H.C. Wainwright conference
- BioCardia is set to present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York.
- CEO Peter Altman is slated to update investors on CardiAMP regulatory timelines in Japan and U.S. progress in the CardiAMP HF II trial.
- The presentation is also expected to cover Helix transendocardial delivery platform regulatory work and Heart3D fusion imaging platform development.
•
